FDA NDC Directory · JSON-LD · Markdown
NDC 69097-686 · HUMAN PRESCRIPTION DRUG · SOLUTION
| Labeler / Manufacturer | Cipla USA Inc. |
|---|---|
| Marketing category | Abbreviated NDA (generic) · App ANDA212224 |
| Dosage form / route | SOLUTION · TOPICAL |
| Active ingredients | TAVABOROLE (43.5 mg/mL) |
| Marketing started | 20210218 |
| Package count | 1 |
Source: openFDA. Public-domain (CC0).